590
Participants
Start Date
June 30, 2005
Primary Completion Date
September 30, 2006
Study Completion Date
September 30, 2006
Certolizumab Pegol
Montgomery
Sun City West
Palm Desert
Pasadena
Santa Maria
Naples
Palm Harbor
South Miami
New Orleans
St Louis
New Brunswick
Stratford
New York
Rochester
Canfield
Wynnewood
San Antonio
Pleven
Sofia
Stara Zagora
Santiago
Temuco
Rijeka
Brno
Hlučín
Ostrava-Poruba
Prague
Sokolov
UherskeHradiste
Zlín
Tallinn
Afula
Ashkelon
Beer Yaakov
Haifa
Jerusalem
Ramat Gan
Rehovot
Daugavpils
Riga
Alytus
Kaunas
Klaipėda
Panevezys
Šiauliai
D. F.
Mexicalli
México
Monterrey
Tijuana
Bialystok
Elblag
Krakow
Lublin
Sopot
Torun
Moscow
Saint Petersburg
Yaroslavl
Belgrade
Niška Banja
Novi Sad
Košice
Piešťany
Dnipro
Donetsk
Ivano-Frankivsk
Kiev
Simferopol
Zaporizhzhya
Lead Sponsor
UCB Pharma
INDUSTRY